🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Safety and tolerability evaluation of erenumab: Expert Opinion on Drug Safety. ⁦Human Migraine Research Unit⁩ ⁦Dimos Mitsikostas⁩ ⁦European Headache Federation⁩ ⁦International Headache Society⁩ ⁦Rigshospitalet⁩ ⁦⁦Lægemiddelstyrelsen⁩ tandfonline.com/doi/full/10.10…

Special Issue "Monoclonal Antibodies for #Migraine Prevention“ is Open for Submission: #MonoclonalAntibodies Prof. Dimos D. Mitsikostas is serving as the Guest Editor. 👉View Details Via: mdpi.com/journal/pharma…

What Do We Know So Far for the #MonoclonalAntibodies Targeting #CGRP? #Erenumab #Fremanezumab #Galcanezumab #Eptinezumab 📄Find Out More Via this Review Paper by Dr. Theodoros Mavridis et al.: mdpi.com/1424-8247/14/7…

Duration and onset of effect of incobotulinumtoxina for the treatment of blepharospasm in botulinum toxin-naïve subjects tandfonline.com/doi/full/10.10…

1 billion people worldwide 🌎live with #migraine disease🧠It does not discriminate against, age, gender, or race. Migraine often runs in families and is passed down through generations 👩‍👩‍👧‍👦 Where are you in the world and what age were you when you had your first #migraineattack?

Πανευρωπαϊκή Ημέρα Δράσης για την Κεφαλαλγία: Εκστρατεία ενημέρωσης όλο τον Σεπτέμβριο | Reader reader.gr/ygeia/384159/p…

Αθηναϊκό Πρακτορείο Ειδήσεων - Μακεδονικό Πρακτορείο Ειδήσεων: home amna.gr/home/article/5…

Vaccines | Free Full-Text | Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers mdpi.com/2076-393X/9/10…

Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers mdpi.com/1312350 #mdpivaccines via MDPI

A wonderful celebration of the Brain Prize 2021 with HRH Crown Prince Frederik

🙌In case you have missed it, here is our #HighlyCitedPaper "#Monoclonal #Antibodies as #Neurological Therapeutics" by Panagiotis Gklinos et al. Full text is available at: 👉mdpi.com/1424-8247/14/2… 📍University of Athens Sanofi

You deserve the best treatment!!!!

67 Neurocases Report, 7th National Forum for Neuroloy, Poros Sirene Blue Resort, 8-10 Sep 2022

Hellenic Headache Society Recommendations for the Use of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide Pathway for the Prevention of Migraine and Cluster Headache—2023 Update | SpringerLink link.springer.com/article/10.100…

Via The Lancet Neurology: A single dose of 75 mg rimegepant effectively treated migraine with safety and tolerability similar to those of a placebo: bit.ly/3ItHufG #neurotwitter American Academy of Neurology

eanvirtualcongress.org/ean/ean2023/en… In a few minutes

The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside | Nature Reviews Neurology. ⁦International Headache Society⁩ ⁦European Headache Federation⁩ ⁦European Academy of Neurology⁩ ⁦American Headache Society⁩ ⁦Human Migraine Research Unit⁩ ⁦⁦Dimos Mitsikostas⁩ 👇 nature.com/articles/s4158…

We provide evidence that cAMP-evoked migraine attacks do not require CGRP receptor activation. These findings highlight the relevance of targeting downstream signaling pathways👇Brain ⁦International Headache Society⁩⁩ ⁦Human Migraine Research Unit⁩ ⁦European Headache Federation academic.oup.com/brain/advance-…

why we should not stop anti-CGRP prophylactic treatment for migraine for regulatory reasons - re-administration has less effectiveness of the treatment causing unnecessary suffering for our patients, acnr.co.uk/data-challenge…